SynBiotic SE (ETR:SBX)
Germany · Delayed Price · Currency is EUR 1.054
0.00 (0.00%)
Aug 12, 2026, 5:35 PM CET
SynBiotic SE Company Description
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe.
It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products.
The company was incorporated in 2024 and is based in Düsseldorf, Germany.
SynBiotic SE
| Country | Germany |
| Founded | 2024 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 79 |
| CEO | Daniel Kruse |
Contact Details
Address: Münsterstraße 336 Düsseldorf, 40470 Germany | |
| Website | synbiotic.com |
Stock Details
| Ticker Symbol | SBX |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A3E5A59 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Kruse | MD and Director |
| Rebecca Kruse-Rosetti | ?Head of Finance |